GGrantIndex
← Leaderboards

Cammie Lesser

Massachusetts General Hospital

Google Scholar ↗PubMed ↗ORCID ↗
$16,591,943
Attributed
$19,082,260
Total exposure
15
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,082,260 · 15

By mechanism

R01$13,825,382 · 5
R21$3,941,421 · 8
R56$948,264 · 1
K08$367,193 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Proteins”

Research focus

ProteinsMediatingCellsInfectionPathogenVirulenceShigellaBaseCytosolMammalian CellBacteriaEscherichia ColiLaboratoriesPathogenesisType Iii Secretion System PathwayPathogenic BacteriaCytokineComplexMolecularResponseEngineeringEpithelial CellsCell PhysiologyInsight

Grant awards (52)

Shigella mediated regulation of epithelial cell inflammasomes$752,519
R01 · FY2025 · AI · contact PI
Shigella mediated regulation of epithelial cell inflammasomes$750,070
R01 · FY2024 · AI · contact PI
Shigella mediated regulation of epithelial cell inflammasomes$761,640
R01 · FY2023 · AI · contact PI
Dissecting the means by which type 3 substrates are defined & secreted$500,879
R01 · FY2023 · AI · contact PI
Designer EcN for treatment of solid tumors$190,994
R21 · FY2023 · CA · contact PI
Dissecting the means by which type 3 substrates are defined & secreted$31,342
R01 · FY2023 · AI · contact PI
Shigella suppression of epithelial cell death$513,055
R56 · FY2022 · AI · contact PI
Dissecting the means by which type 3 substrates are defined & secreted$510,384
R01 · FY2022 · AI · contact PI
Designer EcN for treatment of solid tumors$249,442
R21 · FY2022 · CA · contact PI
Dissecting the means by which type 3 substrates are defined & secreted$128,727
R01 · FY2022 · AI · contact PI
Dissecting the means by which type 3 substrates are defined & secreted$510,186
R01 · FY2021 · AI · contact PI
Designer probiotics for prevention of cholera$248,600
R21 · FY2021 · AI · contact PI
Dissecting the means by which type 3 substrates are defined & secreted$97,385
R01 · FY2021 · AI · contact PI
Designer Probiotics for the treatment of intestinal infection and inflammation$733,448
R01 · FY2020 · DK · contact PI
Dissecting the means by which type 3 substrates are defined & secreted$510,186
R01 · FY2020 · AI · contact PI
Designer probiotics for prevention of cholera$210,000
R21 · FY2020 · AI · contact PI
Designer Probiotics for the treatment of intestinal infection and inflammation$735,149
R01 · FY2019 · DK · contact PI
Dissecting the means by which type 3 substrates are defined & secreted$510,186
R01 · FY2019 · AI · contact PI
Designer Probiotics for the treatment of intestinal infection and inflammation$735,149
R01 · FY2018 · DK · contact PI
Shigella and macrophage cell death$256,500
R21 · FY2018 · AI · contact PI
Designer Probiotics for the treatment of intestinal infection and inflammation$744,110
R01 · FY2017 · DK · contact PI
Manipulation of epithelial cells by Shigella$435,000
R01 · FY2017 · AI · contact PI
Shigella and macrophage cell death$213,750
R21 · FY2017 · AI · contact PI
Designer Probiotics for the treatment of intestinal infection and inflammation$787,620
R01 · FY2016 · DK · contact PI
Manipulation of epithelial cells by Shigella$435,000
R01 · FY2016 · AI · contact PI
Manipulation of epithelial cells by Shigella$435,000
R01 · FY2015 · AI · contact PI
PIPs: a new means to identify effector-target interactions$261,000
R21 · FY2015 · AI · contact PI
Manipulation of epithelial cells by Shigella$435,000
R01 · FY2014 · AI · contact PI
Anti-inflammatory promoting commensal E. coli$257,875
R21 · FY2014 · AI · contact PI
PIPs: a new means to identify effector-target interactions$217,500
R21 · FY2014 · AI · contact PI
Anti-inflammatory promoting commensal E. coli$218,903
R21 · FY2013 · AI · contact PI
Manipulation of epithelial cells by Shigella$204,450
R01 · FY2013 · AI · contact PI
Manipulation of epithelial cells by Shigella$435,209
R56 · FY2012 · AI · contact PI
Bacterial mediated generation of iPS cells$350,460
R01 · FY2012 · GM · contact PI
Dissecting the roles of superchaperones in type III secretion$265,500
R21 · FY2012 · AI · contact PI
Bacterial mediated generation of iPS cells$350,460
R01 · FY2011 · GM · contact PI
Dissecting the roles of superchaperones in type III secretion$221,250
R21 · FY2011 · AI · contact PI
Modeling mechanisms of Shigella pathogenesis in yeast$371,317
R01 · FY2010 · AI · contact PI
Bacterial mediated generation of iPS cells$354,000
R01 · FY2010 · GM · contact PI
MAPK phosphatases and innate immunity$219,038
R21 · FY2010 · AI · contact PI
Modeling mechanisms of Shigella pathogenesis in yeast$100,000
R01 · FY2010 · AI · contact PI
Modeling mechanisms of Shigella pathogenesis in yeast$375,067
R01 · FY2009 · AI · contact PI
MAPK phosphatases and innate immunity$275,794
R21 · FY2009 · AI · contact PI
Modeling mechanisms of Shigella pathogenesis in yeast$375,067
R01 · FY2008 · AI · contact PI
Modeling mechanisms of Shigella pathogenesis in yeast$382,331
R01 · FY2007 · AI · contact PI
Modeling mechanisms of Shigella pathogenesis in yeast$423,250
R01 · FY2006 · AI · contact PI
Novel Genetic Analyses of Shigella virulence proteins$341,775
R21 · FY2006 · AI · contact PI
Novel Genetic Analyses of Shigella virulence proteins$293,500
R21 · FY2005 · AI
The role of Yersinia YopM in pathogenesis$124,070
K08 · FY2004 · AI
The role of Yersinia YopM in pathogenesis$124,070
K08 · FY2003 · AI
The role of Yersinia YopM in pathogenesis$69,927
K08 · FY2002 · AI
The role of Yersinia YopM in pathogenesis$49,126
K08 · FY2002 · AI